Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis

Microbes and Infection

Volumn 9, Issue 11, 2007, Pages 1359-1367

  Jarešová, Irena ^a   Rožková, Daniela ^a   Špíšek, Radek ^b   Janda, Aleš ^a   Brázová, Jitka ^a   Šedivá, Anna ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Alternative splicing; Cystic fibrosis; Toll like receptor 4

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE; GENE EXPRESSION; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TOLL LIKE RECEPTOR 4 GENE; UPREGULATION;

ADULT; ALTERNATIVE SPLICING; ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; CYSTIC FIBROSIS; DENDRITIC CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; NEGIBACTERIA;

EID: 35148842078     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.06.009     Document Type: Article

References (32)

1. Kawai T., and Akira S. TLR signaling. Cell Death Differ. 13 (2006) 816-825
2. Akira S. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15 (2003) 5-11
3. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
4. West M.A., and Heagy W. Endotoxin tolerance: A review, Crit. Care Med. 30 (2002) S64-S73
5. Fan H., and Cook J.A. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10 (2004) 71-84
6. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., and Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100 (2003) 171-194
7. Liew F.Y., Xu D., Brint E.K., and O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5 (2005) 446-458
8. Kobayashi K., Hernandez L.D., Galan J.E., Janeway Jr. C.A., Medzhitov R., and Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110 (2002) 191-202
9. Wald D., Qin J., Zhao Z., Qian Y., Naramura M., Tian L., Towne J., Sims J.E., Stark G.R., and Li X. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4 (2003) 920-927
10. Brint E.K., Xu D., Liu H., Dunne A., McKenzie A.N., O'Neill L.A., and Liew F.Y. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5 (2004) 373-379
11. Haehnel V., Schwarzfischer L., Fenton M.J., and Rehli M. Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168 (2002) 5629-5637
12. Hardy M.P., and O'Neill L.A. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279 (2004) 27699-27708
13. LeBouder E., Rey-Nores J.E., Rushmere N.K., Grigorov M., Lawn S.D., Affolter M., Griffin G.E., Ferrara P., Schiffrin E.J., Morgan B.P., and Labeta M.O. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171 (2003) 6680-6689
14. Iwami K.I., Matsuguchi T., Masuda A., Kikuchi T., Musikacharoen T., and Yoshikai Y. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165 (2000) 6682-6686
15. Ernst R.K., Yi E.C., Guo L., Lim K.B., Burns J.L., Hackett M., and Miller S.I. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286 (1999) 1561-1565
16. Rozkova D., Horvath R., Bartunkova J., and Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin. Immunol. 120 (2006) 260-271
17. Modrek B., Resch A., Grasso C., and Lee C. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 29 (2001) 2850-2859
18. Jordan T., Schornack S., and Lahaye T. Alternative splicing of transcripts encoding Toll-like plant resistance proteins - what's the functional relevance to innate immunity?. Trends Plant Sci. 7 (2002) 392-398
19. Bosisio D., Polentarutti N., Sironi M., Bernasconi S., Miyake K., Webb G.R., Martin M.U., Mantovani A., and Muzio M. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99 (2002) 3427-3431
20. Armstrong L., Medford A.R., Hunter K.J., Uppington K.M., and Millar A.B. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin. Exp. Immunol. 136 (2004) 312-319
21. Visintin A., Mazzoni A., Spitzer J.H., Wyllie D.H., Dower S.K., and Segal D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166 (2001) 249-255
22. Hadley J.S., Wang J.E., Foster S.J., Thiemermann C., and Hinds C.J. Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling. Infect. Immun. 73 (2005) 7613-7619
23. Medvedev A.E., Lentschat A., Wahl L.M., Golenbock D.T., and Vogel S.N. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169 (2002) 5209-5216
24. Greene C.M., Carroll T.P., Smith S.G.J., Taggart C.C., Devaney J., Griffin S., O'Neill S.J., and McElvaney N.G. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 174 (2005) 1638-1646
25. Muir A., Soong G., Sokol S., Reddy B., Gomez M.I., Van Heeckeren A., and Prince A. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30 (2004) 777-783
26. Faure K., Sawa T., Ajayi T., Fujimoto J., Moriyama K., Shime N., and Wiener-Kronish J.P. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir. Res. 5 (2004) 1
27. Joseph T., Look D., and Ferkol T. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell Mol. Physiol. 288 (2005) L471-L479
28. Pfeffer K.D., Huecksteadt T.P., and Hoidal J.R. Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am. J. Respir. Cell Mol. Biol. 9 (1993) 511-519
29. Zaman M.M., Gelrud A., Junaidi O., Regan M.M., Warny M., Shea J.C., Kelly C., O'Sullivan B.P., and Freedman S.D. Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin. Diagn. Lab. Immunol. 11 (2004) 819-824
30. DiMango E., Ratner A.J., Bryan R., Tabibi S., and Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Invest. 101 (1998) 2598-2605
31. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., and Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 164 (2000) 3476-3479
32. Diterich I., Rauter C., Kirschning C.J., and Hartung T. Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect. Immun. 71 (2003) 3979-3987